European Organisation for Research and Treatment of Cancer

It develops, conducts, coordinates and stimulates high-quality translational and clinical trial research to improve the survival and quality of life of cancer patients.

The EORTC's mission is to increase people's survival and quality of life by testing new therapeutic strategies based on existing drugs, surgery and radiotherapy.

In order to follow changing regulatory requirements, the EORTC regularly converses with the US Food and Drug Administration and the European Medicines Evaluation Agency.

Princess Dina Mired of Jordan is the Honorary President and Count Diego du Monceau de Bergendal chairs the Board of Directors of the ECRF.

Additional contributions and sponsorship are vital to cover these scientific activities where the main goal is to effectively promote European cancer clinical research.